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ABSTRACT 
Context Several surgical complications are related to obesity. Objective This study evaluated the impact of obesity on pancreatic 
fistula after pancreaticoduodenectomy. Design We retrospectively reviewed the medical records of 159 patients who underwent 
pancreaticoduodenectomy between October 2002 and December 2008. Setting The patients were divided according to the body 
mass index as obese (body mass index equal to, or greater than, 25 kg/m2), or normal (body mass index less than 25 kg/m2). 
Methods Univariate and multivariate analyses were applied. Two-tailed P values less than 0.05 were considered as significant. 
Results Forty-six patients (28.9%) were obese and 113 patients (71.1%) were normal-weight. Obese group had a significantly higher 
incidence of pancreatic fistula and a greater amount of intraoperative blood loss. Other surgical complications were not significantly 
different between the two groups. Multivariate analysis found obesity, small pancreatic duct size (less than, or equal to, 3 mm), 
intraoperative blood loss, and combined resection as significant factors affecting pancreatic fistula. Conclusions Obese patients have 
an increased risk for pancreatic fistula after pancreaticoduodenectomy. 
 
INTRODUCTION 
 
Pancreaticoduodenectomy performed in high volume 
centers has become increasingly safe and more 
efficient. However, the morbidity rate remains high 
with complication rates of around 40%. The major 
complication leading to serious results is pancreatic 
fistula and well-known main risk factors of pancreatic 
fistula are small pancreatic duct size, and soft texture 
of pancreatic parenchyma [1, 2]. 
Obesity is rapidly becoming a major public health 
problem in many countries around the world. Obesity 
is related with several chronic diseases including 
diabetes mellitus, cardiovascular disease, stroke, 
hypertension and certain cancers. It is also associated 
with perioperative complications and has been 
considered a risk factor for surgical outcomes of 
patients undergoing abdominal surgery [3, 4, 5]. 
Soft pancreas, which is more frequently observed in 
obese patients, could explain why body mass index 
(BMI) appears as a risk factor of pancreatic fistula after 
distal pancreatectomy [6]. There were some studies 
evaluating a correlation between obesity and pancreatic 
fistula after pancreaticoduodenectomy in Western 
countries, and obesity in those studies was defined as 
over 30 kg/m2 of BMI [7, 8]. However, there was a 
debate about obesity criteria for Asian populations, and 
the International Association for the Study of Obesity 
(IASO) and the International Obesity Task Force 
(IOTF) proposed a BMI cut-off point of 25 kg/m2 for 
obesity in Asian populations [9]. 
The aim of this study was to evaluate the impact of 
obesity on pancreatic fistula after pancreatico-
duodenectomy in Asian patients on the basis of Asia-
Pacific perspective of BMI in obesity. 
 
METHODS 
 
Patients 
 
Between October 2002 and December 2008, 159 
patients with benign and malignant periampullary 
lesions underwent pancreaticoduodenectomy by one 
surgeon (D.S.Y.) at the Department of Surgery, 
Gangnam Severance Hospital, Yonsei University 
College of Medicine. 
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Surgical Procedures 
 
Pylorus preserving pancreaticoduodenectomy and 
conventional pancreaticoduodenectomy were performed 
in previously reported manners [10]. 
As a first step in reconstruction, the proximal jejunum 
was brought through the transverse mesocolon by the 
retrocolic route. Pancreaticojejunostomy was 
performed with duct-to-mucosa anastomosis in all 
patients. The inner layer was duct-to-mucosa with 
interrupted 5-0 polypropylene sutures, and a short 
internal stent was used. The outer layer was a 
seromuscular envelope with interrupted 4-0 polyglactin 
Lambert sutures. End-to-side hepaticojejunostomy (or 
choledochojejunostomy) was performed 15 cm 
proximal to the pancreaticojejunostomy with single-
layer interrupted sutures. An antecolic duodeno-
jejunostomy (or gastrojejunostomy) was constructed 
using a two-layered anastomosis. After reconstruction, 
a tube gastrostomy was routinely performed instead of 
using a nasogastric tube. Tube gastrostomy was 
performed as follows: a small gastrostomy was made in 
the anterior wall of the stomach, and an 18 Fr balloon 
catheter was inserted. The tube was exteriorized 
through the abdominal wall and was fixed to the skin. 
A closed suction, silicon drain (Jackson-Pratt, Baxter 
Health Care Corp., Deerfield, IL, USA), was placed 
from the right upper quadrant posterior to the 
pancreaticojejunal and biliary anastomosis.  
Assessment of Pancreas Consistency  
In all cases, pancreatic duct diameter was measured 
after pancreatic transection by the operator. 
Parenchyma texture was divided into two groups based 
upon the extent of fibrotic changes in the resection 
margin. A fibrotic change was assessed by trichrome 
staining. Soft pancreatic parenchyma was characterized 
by the absence of fibrosis or slight thickness of 
perilobular fibrosis (up to 50 μm). Hard parenchyma 
was characterized by thick perilobular fibrosis greater 
than 50 μm (Figure 1).  
Perioperative Management  
According to the department policy, all patients 
received anti-acid drugs for stress ulcer prophylaxis, 
and octreotide (Sandostatin® 0.1 mg; Novartis 
International, Basel, Switzerland) was administered 
subcutaneously for 7 days postoperatively. Gastric 
suction through the gastrostomy tube was stopped 
within the first 3 postoperative days. After 
postoperative day 3, the gastrostomy tube was clamped 
for 24 hours, and patients were given sips of water 
Figure 1. Results of trichrome staining on the resection margin of the pancreas. a. b. Absence of fibrosis or slight thickness of perilobular fibrosis 
(less than, or equal to,50 μm ). c. d. Hard parenchyma was characterized by thick perilobular fibrosis greater than 50 μm. The purple color stained by 
trichrome show the component of fibrotic change in perilobular space. 
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between postoperative days 4 and 5. Patients then 
proceeded to a regular diet within 7 days. 
 
Classification of Pancreatic Fistula and Delayed 
Gastric Emptying 
 
Pancreatic fistula is defined by output via an operative 
drain of any measurable volume of drain fluid on or 
after postoperative day 3 with amylase content greater 
than three times the upper normal serum level (more 
than 300 IU/L) according to the definition given by the 
International Study Group of Pancreatic Fistula 
(ISGPF) [11]. The grade of pancreatic fistula was 
divided as grade A, B and C according to the severity 
of pancreatic fistula. And we redefined the pancreatic 
fistula according to the clinical importance. Clinically 
relevant pancreatic fistula including grade B and C 
were redefined as ‘Clinical Yes’ group, the other group 
including absence of pancreatic fistula and grade A 
were redefined as ‘Clinical No’ group. 
The severity of delayed gastric emptying was 
determined according to the classification scheme 
proposed by the International Study Group of 
Pancreatic Surgery (ISGPS) [12]. In this classification, 
delayed gastric emptying is defined by the need for 
maintenance of nasogastric tube for 3 days, need for 
reinsertion of nasogastric tube for persistent vomiting 
after postoperative day 3, or inability to tolerate a solid 
diet by postoperative day 7. The present study 
evaluated delayed gastric emptying based on tube 
gastrostomy period instead of nasogastric tube period. 
 
ETHICS 
 
This study was approved by the Institutional Review 
Board of Yonsei University for retrospective chart 
review and data collection. Any written or oral 
informed consent was not obtained from each patient. 
However, the study protocol conformed to the ethical 
guidelines of the “World Medical Association 
Declaration of Helsinki - Ethical Principles for Medical 
Research Involving Human Subjects”. 
 
STATISTICS 
 
Continuous variables are expressed as the mean ± 
standard deviation (SD) or median and interquartile 
range (IQR) with skewed distributions. Differences 
between groups were analyzed by using the Mann-
Whitney, the linear-by-linear association chi-square, or 
the Fisher’s exact tests. To test the independence of the 
risk factors, all variables tested in univariate analysis 
but hospital stay (because it was not an influencing 
factor, but just a result of pancreatic fistula) were 
entered into a stepwise multivariate nonconditional 
logistic regression model and the odds ratios and the 
95% confidence intervals were also evaluated. Two-
tailed P values less than 0.05 were considered 
significant. 
Table 1. Characteristics of patients according to the body mass index (BMI).
Variables Normal: BMI <25 kg/m2 (n=113) Obese: BMI ≥25 kg/m2 (n=46) P value 
Age (years); mean±SD 59.3±11.2 62.2±13.4 0.090 a 
Gender: 
- Male 
- Female 
 
66 (58.4%) 
47 (41.6%) 
 
24 (52.2%)  
22 (47.8%)  
0.486 b 
Body mass index (kg/m2); mean±SD 21.9±2.2 27.0±2.0 <0.001 a 
Comorbid disease 58 (51.3%) 23 (50.0%) 1.000 b 
Presence of diabetes mellitus 40 (35.4%) 19 (41.3%) 0.587 b 
Presence of hypertension 21 (18.6%) 13 (28.3%) 0.203 b 
Type of operation: 
- Pancreaticoduodenectomy 
- Pylorus preserving pancreaticoduodenectomy 
 
39 (34.5%) 
74 (65.5%) 
 
12 (26.1%) 
34 (73.9%) 
0.352 b 
Combined resection (PV or SMV) 11 (9.7%) 0 0.034 b 
Pathology: 
- Malignancy 
- Benign 
 
96 (85.0%)  
17 (15.0%) 
 
37 (80.4%)  
9 (19.6%) 
0.486 b 
Pancreatic duct size (mm); mean±SD: 
- Less than, or equal to, 3 mm 
- Greater than 3 mm 
3.7±2.2 
69 (61.1%) 
44 (38.9%) 
3.5±1.7 
27 (58.7%) 
19 (41.3%) 
0.873 a  
0.859 b 
Operation time (min); median (IQR) 420 (360-514)  455 (400-540) 0.347 a 
Intra-operative blood loss (mL); median (IQR) 1,000 (600-1,550) 1,200 (900-1,625) 0.031 a 
Transfusion (unit); median (IQR) 1 (0-3) 2 (0-3) 0.390 a 
Pancreas texture: 
- Soft 
- Hard 
 
26 (23.0%) 
87 (77.0%) 
 
14 (30.4%) 
32 (69.6%) 
0.420 b 
Preoperative jaundice 73 (64.6%) 29 (63.0%) 0.857 b 
Hospital stay (days); median (IQR) 23 (20-31) 25 (21-31) 0.555 a 
IQR: interquartile range; PV: portal vein; SD: standard deviation; SMV: superior mesenteric vein  
a Mann-Whitney test 
b Fisher’s exact test 
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RESULTS 
 
A total of 159 patients who underwent pancreatico-
duodenectomy (or pylorus preserving pancreatico-
duodenectomy) were selected for this study. The 
average age (±SD) of patients was 60.2±11.9 years, and 
90 of them (56.6%) were men. The median BMI was 
23.4 kg/m2 (IQR: 21.5-25.3 kg/m2), the median 
intraoperative blood loss was 1,100 mL (IQR: 700-
1,600 mL), the median operative time was 425 min 
(IQR: 375-530 min), and the median duration of 
hospital stay was 24 days (IQR: 21-31 days). 
Fifty-one patients (32.1%) underwent pancreatico-
duodenectomy, and 108 (67.9%) underwent pylorus 
preserving pancreaticoduodenectomy. Pathologic 
diagnoses were pancreatic carcinoma in 45 patients 
(28.3%), benign pancreas disease (chronic pancreatitis 
or pancreatic cystic neoplasms) in 15 (9.4%), bile duct 
cancer in 45 (28.3%), benign biliary disease in 3 
(1.9%), ampulla of Vater carcinoma in 35 (22.0%), 
adenoma of the ampulla of Vater in 7 (4.4%), duodenal 
carcinoma in 8 (5.0%), and pancreas head trauma in 1 
(0.6%). 
Forty-six patients (28.9%) were obese which is defined 
as BMI over 25 kg/m2, and 113 patients (71.1%) were 
normal-weight as defined by the Asia-Pacific 
perspectives criteria [6]. 
Demographic and clinical data of both groups are 
shown in Table 1. The two groups showed no 
significant differences in age, sex, comorbidity, size of 
pancreatic duct and texture of pancreas parenchyma. 
However, there was significantly larger amount of 
intraoperative blood loss in obese group while 
combined resection was made in normal group only. 
There were no cases of hospital mortality (within 30 
days). 
Ninety-two patients (57.9%) had one or more 
postoperative complications: 55 patients (34.6%) had 
one complication, 33 patients (20.8%) had two 
complications and 4 patients (2.5%) had three 
complications. In addition, routine abdominal CT scan 
at the 7th postoperative day showed simple intra-
abdominal fluid collection or ascites in two patients 
(1.3%) with BMI less than 25 kg/m2. We did not 
include these data as complications; one of these 
patients had other postoperative complications. 
There was no significant difference in postoperative 
complications in both groups except pancreatic fistula 
(Table 2). Pancreatic fistula was the most common 
complication in this study. Sixty-three patients (39.6%) 
Table 2. Postoperative complications according to the body mass index (BMI). 
Complication Normal: BMI <25 kg/m2 (n=113) Obese: BMI ≥25 kg/m2 (n=46) P value 
Pancreatic fistula: 
- No 
- Grade A 
- Grade B 
- Grade C 
Incidence of pancreatic fistula (grade A/B/C) 
Clinical pancreatic fistula (grade B/C) 
 
75 (66.4%) 
25 (22.1%) 
12 (10.6%) 
1 (0.9%) 
38 (33.6%) 
13 (11.5%) 
 
21 (45.7%) 
11 (23.9%) 
11 (23.9%) 
3 (6.5%) 
25 (54.3%) 
14 (30.4%) 
0.002 a 
 
 
 
 
0.020 b 
0.009 b 
Delayed gastric emptying 33 (29.2%) 18 (39.1%) 0.262 b 
Wound infection 6 (5.3%) 6 (13.0%) 0.107 b 
Bleeding 1 (0.9%) 0 1.000 b 
Chyle peritonitis 4 (3.5%) 0 0.324 b 
Brain infarction 2 (1.8%) 0 1.000 b 
Mortality 0 0 - 
a Linear-by-linear association chi-square test 
b Fisher’s exact test 
Table 3. Univariate analysis of risk factors for pancreatic fistula
(dichotomic variables). 
Factor Frequency of 
pancreatic fistula
P value a
Gender: 
- Male 
- Female 
 
37/90 (41.1%) 
26/69 (37.7%) 
0.744 
Body mass index: 
- <25 kg/m2 
- equal to, or grater than, 25 kg/m2 
 
38/113 (33.6%)
25/46 (54.3%) 
0.020 
Comorbid disease: 
- Yes 
- No 
 
35/81 (43.2%) 
28/78 (35.9%) 
0.418 
Diabetes mellitus: 
- Yes 
- No 
 
26/59 (44.1%) 
37/100 (37.0%) 
0.405 
Hypertension: 
- Yes 
- No 
 
16/34 (47.1%) 
47/125 (37.6%) 
0.330 
Type of operation: 
- Pancreaticoduodenectomy 
- Pylorus preserving 
pancreaticoduodenectomy 
 
20/51 (39.2%) 
43/108 (39.8%) 
1.000 
Combined resection (PV or SMV): 
- Yes 
- No 
 
7/11 (63.6%) 
56/148 (37.8%) 
0.115 
Pathology: 
- Malignancy 
- Benign 
 
53/133 (39.8%)
10/26 (38.5%) 
1.000 
Pancreatic duct size: 
- less than, or equal to, 3 mm 
- >3 mm 
 
49/96 (51.0%) 
14/63 (22.2%) 
<0.001 
Pancreas texture: 
- Soft 
- Hard 
 
23/40 (57.5%) 
40/119 (33.6%) 
0.009 
Preoperative jaundice: 
- Yes 
- No 
 
42/102 (41.2%)
21/57 (36.8%) 
0.616 
a Fisher’s exact test 
PV: portal vein; SMV: superior mesenteric vein 
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developed pancreatic fistula: 36 (22.6 %) patients had 
grade A, 23 (14.5 %) grade B, and 4 (2.5%) grade C. 
The incidence of pancreatic fistula was significantly 
higher in obese group (P=0.020) as well as the grade of 
pancreatic fistula was positively related to obesity 
(P=0.002). 
In univariate analysis, the incidence of pancreatic 
fistula was significantly greater in patients with BMI 
over 25 kg/m2, small pancreatic duct size (less, or equal 
to, 3 mm), and soft pancreatic texture. Patients with 
pancreatic fistula had also longer operative time and 
large amount of both intraoperative blood loss and 
transfusion. The rates of pancreatic fistula did not 
correlated with age, sex, operation method 
(pancreaticoduodenectomy versus pylorus preserving 
pancreaticoduodenectomy), preoperative medical 
disease history (diabetes mellitus, hypertension), 
pathology (benign or malignant), and preoperative 
jaundice (Tables 3 and 4). 
In multivariate analysis, BMI over 25 kg/m2, small 
pancreatic duct size (less, or equal to, 3 mm), 
intraoperative blood loss, and combined resection were 
identified as independent factors for pancreatic fistula 
(Table 5). 
When we re-evaluated the pancreatic fistula as 
clinically relevant pancreatic fistula, like as ‘Clinical 
Yes’ group and ‘Clinical No’ group, univariate analysis 
showed BMI over 25 kg/m2, preoperative jaundice, 
longer operative time, and large amount of both 
intraoperative blood loss and transfusion were 
significantly related to clinically relevant pancreatic 
fistula. However, small pancreatic duct size (less, or 
equal to, 3 mm) (P=0.052) and soft pancreatic texture 
(P=0.052) had marginal significance on clinically 
relevant pancreatic fistula (Tables 6 and 7). In the 
multivariate analysis of clinically relevant pancreatic 
fistula, BMI over 25 kg/m2, soft pancreatic texture, and 
intraoperative blood loss were confirmed as 
independent risk factors together with preoperative 
jaundice, whereas small pancreatic duct did not enter 
this analysis (Table 8). 
 
DISCUSSION 
 
Public health issues related with obesity are rapidly 
increasing throughout Asia as well as in developed 
Table 4. Univariate analysis of risk factors for pancreatic fistula (scale variables). 
Pancreatic fistula Factor 
Yes (n=63) No (n=96) 
P value a 
Age (years): mean±SD 60.8±11.1 59.7±12.5 0.719 
Pancreatic duct size (mm); median (IQR) 2 (2-3) 4 (2-5) <0.001 
Operation time (min); median (IQR) 480 (415-580) 420 (360-480) 0.001 
Intra-operative blood loss (mL); median (IQR) 1,400 (1,000-1,900) 900 (600-1,300) <0.001 
Transfusion (unit); median (IQR) 2 (1-3) 1 (0-2) 0.001 
Hospital stay (days); median (IQR) 26 (21-37) 23 (19-29) 0.002 
a Mann-Whitney test 
IQR: interquartile range; SD: standard deviation 
Table 5. Stepwise multivariate analysis of the factors for pancreatic 
fistula. 
 Odds ratio 
(95% confidence interval)
P value
BMI equal to, or grater than, 
25 kg/m2 
2.939 (1.324-6.521) 0.008 
Small pancreatic duct (≤3 mm) 4.169 (1.887-9.209) <0.001
Intra-operative blood loss a 1.088 (1.032-1.148) 0.002 
Combined resection 4.728 (1.081-20.679) 0.039 
a Odds ratio estimates the risk of pancreatic fistula related to the 
increase of 100 mL in blood loss 
Table 6. Univariate analysis of risk factors for “Clinical Yes”
pancreatic fistula (dichotomic variables). 
Factor Frequency of 
“Clinical Yes” 
pancreatic fistula
(grades B and C)
P value a
Gender: 
- Male 
- Female 
 
17/90 (18.9%) 
10/69 (14.5%) 
0.527 
Body mass index: 
- <25 kg/m2 
- equal to, or grater than,25 kg/m2 
 
13/113 (11.5%)
14/46 (30.4%) 
0.009 
Comorbid disease 
- Yes 
- No 
 
15/81 (18.5%) 
12/78 (15.4%) 
0.675 
Diabetes mellitus: 
- Yes 
- No 
 
13/59 (22.0%) 
14/100 (14.0%) 
0.198 
Hypertension: 
- Yes 
- No 
 
7/34 (20.6%) 
20/125 (16.0%) 
0.607 
Type of operation: 
- Pancreaticoduodenectomy 
- Pylorus preserving 
pancreaticoduodenectomy 
 
9/51 (17.6%) 
18/108 (16.7%) 
1.000 
Combined resection (PV or SMV): 
- Yes 
- No 
 
1/11 (9.1%) 
26/148 (17.6%) 
0.692 
Pathology: 
- Malignancy 
- Benign 
 
23/133 (17.3%)
4/26 (15.4%) 
1.000 
Pancreatic duct size: 
- less than, or equal to, 3 mm 
- >3 mm 
 
21/96 (21.9%) 
6/63 (9.5%) 
0.052 
Pancreas texture: 
- Soft 
- Hard 
 
11/40 (27.5%) 
16/119 (13.4%) 
0.052 
Preoperative jaundice: 
- Yes 
- No 
 
22/102 (21.6%)
5/57 (8.8%) 
0.048 
a Fisher’s exact test 
PV: portal vein; SMV: superior mesenteric vein 
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countries [13]. The World Health Organization (WHO) 
defines obesity based on BMI over 30 kg/m2. However, 
the WHO classification cannot be used for Asians 
because their heights and weights are different from 
Western population. Therefore, Asia-Pacific guidelines 
for obesity concluded that BMI greater than 25 kg/m2 
may be considered as obesity in Asians [9]. So, we 
defined obesity as BMI higher than 25 kg/m2 in this 
study. 
Actually, the prevalence rate of BMI equal to, or grater 
than,25 kg/m2 and BMI equal to, or grater than, 30 
kg/m2 in Korean was 29.5% and 3.0 % in 2001 
according to the National Health Examination and 
Nutrition Survey (KNHENES) data of 1998 [14] and 
2001 [15, 16]. The obesity rate in our study was 28.9 % 
(BMI equal to, or grater than, 25 kg/m2) and 1.9% 
(BMI equal to, or grater than, 30 kg/m2), which was 
similar with the national survey. 
Many reports showed that intraoperative blood loss, 
wound infection rate, and mortality were higher in 
obese patients after abdominal surgery including 
pancreaticoduodenectomy [3, 5, 17, 18, 19]. Our 
results showed that the amount of intraoperative blood 
loss and incidence of pancreatic fistula were 
significantly higher in obese patients, but there was no 
significant difference in other postoperative 
complications. 
In this study, the ISGPF definition of pancreatic fistula 
was used [11]. Pancreatic fistula is a major factor 
remaining morbidity rate unchanged after pancreatico-
duodenectomy, even though its mortality rate is 
decreased to less than 5% in high volume centers. It is 
difficult to evaluate the actual incidence of pancreatic 
fistula, because it has been defined in several ways in 
the literature. In some studies, grade A pancreatic 
fistula was not considered as pancreatic fistula. Noun R 
et al. [20] showed that the rate of clinically relevant 
pancreatic fistula (36.8% vs. 15.1%; P=0.050) was 
significantly increased in obese vs. non-obese patients. 
In that study, pancreatic fistula was defined as ISGPF 
grade B and C fistulas. In our study, ISGPF grade A 
pancreatic fistula was also considered as pancreatic 
fistula. Pancreatic fistula rate was significantly 
different between obese and normal weight patients 
(54.3% vs. 33.6%; P=0.020) (Table 2). If only grades B 
and C were redefined as pancreatic fistula, the rate 
would be more significantly different (30.4% vs. 
11.5%; P=0.009) and this pancreatic fistula rate was 
similar to that observed in other studies. 
Generally accepted risk factors affecting pancreatic 
fistula are soft pancreatic texture and small pancreatic 
duct without dilatation [2]. In this study, BMI equal to, 
or greater than, 25 kg/m2, small pancreatic duct size 
(less than, or equal to, 3 mm), intraoperative blood 
loss, and combined resection were identified as 
independent factors for pancreatic fistula in multi-
variate analysis (Table 5). When we redefined the 
pancreatic fistula as ‘Clinical Yes’ group including the 
ISGPF definition of grades B and C and ‘Clinical No’ 
group including ISGPF grade A and patients who did 
not have pancreatic fistula, in multivariate analysis, 
BMI equal to, or greater than, 25 kg/m2, soft pancreatic 
texture, intraoperative blood loss, and preoperative 
jaundice were significantly meaningful factors (Table 
8). 
Sledzianowski JF et al. reported that soft pancreas, 
which is more frequently observed in obese patients, 
could explain why BMI appears as a risk factor of 
pancreatic fistula after distal pancreatectomy [6]. In our 
results, soft pancreas was slightly more frequently 
observed in obese patients (30.4% vs. 23.0%; 
P=0.420), but there was no significant difference. 
Noun R et al. [20] demonstrated that the amount of 
intrapancreatic fat was increased in 50% of obese 
patients and that this increase positively correlated with 
BMI. The occurrence of pancreatic fistula had a 
correlation with intrapancreatic fat amount (fat amount 
was graded from absent to massive on a four-point 
scale). Mathur et al. [8] proposed that patients who 
develop a postoperative pancreatic fistula have higher 
pancreatic fat levels. Lee SE et al. [21] demonstrated 
that intralobular, interlobular, and total fat were 
significantly elevated in soft pancreatic group using 
magnetic resonance imaging analysis and more patients 
Table 7. Univariate analysis of risk factors for “Clinical Yes” pancreatic fistula (scale variables). 
Pancreatic fistula Factor 
“Clinical Yes”: grades B and C 
(n=27) 
“Clinical No”: No fistula or grade A
(n=132) 
P value a 
Age (years): mean±SD 62.9±11.2 59.6±12.0 0.235 
Pancreatic duct size (mm); median (IQR) 3 (2-3) 3 (2-5) 0.174 
Operation time (min); median (IQR) 480 (450-540) 420 (360-510) 0.003 
Intra-operative blood loss (mL); median (IQR) 1,600 (1,100-2,000) 1,000 (650-1,500) 0.001 
Transfusion (unit); median (IQR) 2 (2-3) 1 (0-3) <0.001 
Hospital stay (days); median (IQR) 34 (24-41) 23 (20-29) <0.001 
a Mann-Whitney test 
IQR: interquartile range; SD: standard deviation 
Table 8. Stepwise multivariate analysis of the factors for “Clinical 
Yes” pancreatic fistula (grades B and C). 
 Odds ratio 
(95% confidence interval)
P value
BMI equal to, or grater than, 
25 kg/m2 
3.293 (1.303-8.327) 0.012 
Preoperative jaundice 3.787 (1.223-11.729) 0.021 
Intra-operative blood loss a 1.113 (1.043-1.188) 0.001 
Soft pancreatic texture 3.094 (1.160-8.255) 0.024 
a Odds ratio estimates the risk of pancreatic fistula related to the 
increase of 100 mL in blood loss 
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in the pancreatic fistula group had a soft pancreatic 
texture. In our results, we did not evaluate the amount 
of intrapancreatic fat from surgical pathology 
specimens, but the textures of pancreas parenchyma, 
graded by thickness of perilobular fibrosis on the 
trichrome staining, were not different between the two 
groups. Also, the pancreatic duct size was not different 
between normal-weight and obese patients. We could 
not demonstrate the reason why pancreatic fistula was 
higher in obese patients in the respect of generally 
accepted risk factors (soft pancreatic texture and small 
pancreatic duct) in this study. However, the amount of 
intrapancreatic fat was proved to be positively 
correlated with BMI influencing soft pancreatic texture 
in other studies [8, 20, 21]. Another of the possible 
theory was that larger blood loss in obese patients 
impair several surgical procedures, induce longer 
operation time and it might negatively affect to 
pancreaticojejunostomy. In this study, blood loss was 
larger in obese patients, but the operation time was not 
different (Table 1). 
In summary, based on retrospective evaluation of 
impact of obesity for pancreatic fistula after 
pancreaticoduodenectomy, obese patients (BMI equal 
to, or grater than, 25 kg/m2) have increased risk for 
pancreatic fistula after pancreaticoduodenectomy. 
Small pancreatic duct size (less than, or equal to, 
3mm), intraoperative blood loss and combined 
resection were also identified as independent factors 
for pancreatic fistula. Therefore, precise operative 
technique to reduce intraoperative blood loss is 
recommended especially in obese patients who have 
soft pancreatic texture. However, we could not 
demonstrate the reason why BMI over 25 kg/m2 had 
the positive correlation with pancreatic fistula. More 
experience and clinical evaluation are necessary. 
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